Abano Healthcare Group Limited provided earnings guidance for the first half of the fiscal year 2016. For the period, the company expects revenue to be AUD 105 million - AUD 109 million, EBITDA to be AUD 11.9 million - AUD 13.1 million, underlying EBITDA to be AUD 12.5 million - AUD 13.7 million, NPAT to be AUD 3.0 million - AUD 3.6 million, and underlying NPAT to be AUD 3.5 million - AUD 4.1 million.